Involvement of Supraspinal Imidazoline Receptors and Descending Monoaminergic Pathways in Tizanidine-Induced Inhibition of Rat Spinal Reflexes

  • Kino Yurika
    Laboratory of CNS Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University
  • Tanabe Mitsuo
    Laboratory of CNS Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University
  • Honda Motoko
    Laboratory of CNS Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University
  • Ono Hideki
    Laboratory of CNS Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University

この論文をさがす

抄録

The neuronal pathways involved in the muscle relaxant effect of tizanidine were examined by measurement of spinal reflexes in rats. Tizanidine (i.v. and intra-4th ventricular injection) decreased the mono- and disynaptic (the fastest polysynaptic) reflexes (MSR and DSR, respectively) in non-spinalized rats. Depletion of central noradrenaline by 6-hydroxydopamine abolished the depressant effect of tizanidine on the MSR almost completely and attenuated the effect on the DSR. Co-depletion of serotonin by 5,6-dihydroxytryptamine and noradrenaline resulted in more prominent attenuation of tizanidine-induced inhibition of the DSR. Supraspinal receptors were then studied using yohimbine- and some imidazoline-receptor ligands containing an imidazoline moiety. Idazoxan (I1, I2, I3, and α2), efaroxan (I1, I3, and α2), and RX821002 (I3 and α2), but not yohimbine, an α2-adrenergic receptor antagonist with no affinity for I receptors, antagonized the inhibitory effects of tizanidine. Thus, supraspinal I receptors (most likely I3) and descending monoaminergic influences are necessary for tizanidine-induced inhibition of spinal segmental reflexes.<br>

収録刊行物

参考文献 (65)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ